Table 3.
The Association of SBP and DBP with All-Cause Mortality stratified by ADL
| BP | N | Rate per 1000 PY | Demo Adjusted* HR (95% CI) |
Adjusted** HR (95% CI) |
|---|---|---|---|---|
| SBP | ||||
|
| ||||
| Without ADL Limitation | ||||
| SBP (per 10 mmHg increase) | 2792 | 58.5 | 0.99 (0.96, 1.02) | 0.97 (0.94,0.99)† |
| SBP | ||||
| ≤ 120 | 587 | 60.8 | 1.00 | 1.00 |
| 121 – 150 | 1587 | 56.2 | 0.87 (0.75, 1.00) | 0.88 (0.76, 1.03) |
| > 150 | 618 | 62.3 | 0.90 (0.76, 1.07) | 0.83 (0.68, 1.00) |
| With ADL Limitation | ||||
| SBP (per 10 mmHg increase) | 755 | 102.9 | 1.01 (0.96, 1.06) | 1.01 (0.96, 1.06) |
| SBP | ||||
| ≤ 120 | 130 | 107.5 | 1.00 | 1.00 |
| 121 – 150 | 450 | 93.7 | 0.83 (0.62, 1.10) | 0.94 (0.70, 1.25) |
| > 150 | 175 | 125.4 | 1.07 (0.77, 1.48) | 1.12 (0.80, 1.58) |
|
| ||||
| DBP | ||||
|
| ||||
| Without ADL Limitation | ||||
| DBP (per 10mmHg increase) | 2792 | 58.5 | 0.98 (0.93, 1.03) | 1.07 (1.01,1.14)† |
| DBP | ||||
| ≤ 65 | 941 | 63.6 | 1.00 | 1.00 |
| 66 – 80 | 1425 | 55.0 | 0.94 (0.83, 1.07) | 1.11 (0.97, 1.27) |
| > 80 | 426 | 59.4 | 0.99 (0.83, 1.18) | 1.30 (1.06,1.61)† |
| With ADL Limitation | ||||
| DBP (per 10mmHg increase) | 755 | 102.9 | 0.93 (0.84, 1.02) | 0.97 (0.88, 1.07) |
| DBP | ||||
| ≤ 65 | 258 | 120.8 | 1.00 | 1.00 |
| 66 – 80 | 366 | 86.7 | 0.68 (0.54,0.86)† | 0.72 (0.57,0.91)† |
| > 80 | 131 | 120.7 | 0.87 (0.63, 1.20) | 0.87 (0.61, 1.24) |
*
adjusted for age, gender, race and education
**
Further adjusted smoking, physical activity, BMI, DM, total cholesterol, cystatin C and HTN meds and SBP or DBP, respectively. P-value for interaction SBP*ADL=0.55, DBP*ADL=0.23
†
p<0.05
‡
p<0.001